This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.
WELL, MEGAN INTERVIEWS REPORTING THAT THERE ARE ABOUT 45% IN ASSESSING DAMAGE AND THAT IS STATEWIDE. THEY’RE EXPECTING THAT NUMBER TO RISE AS THEY CONTINUE TO GET TO SOME OF THESE HARDER AREAS. FALLEN ...
Forbes contributors publish independent expert analyses and insights. Robin Ryan, a career counselor & author covers job search & careers. This voice experience is generated by AI. Learn more. This ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...
'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Trump administration's changes to the CFPB cost Americans $19B, a new report says Bad Bunny ...
If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...
The US is looking to tap the nation’s network of large industrial diesel generators used at data centers, big box stores and elsewhere to help curb rising electricity costs and support the surge in ...
“Paddy Power has had a hugely positive impact on the World Darts Championship over the past two years,” said PDC Chief Executive Matt Porter once the news was announced. “Their creativity, investment ...
This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results